FDA scientists have released documents that show the reason for not approving a booster shot is because there were not enough antibodies produced after the third dose in trials.
While there was an increase in antibodies, it wasn’t enough.
Many people who already had high levels of antibodies saw no increase, and it even raised the question of whether the first two doses were just incredibly effective.
John Moore, a professor of microbiology and immunology at Weill Cornell Medical College in New York interviewed with Yahoo News and discussed the FDA and what questioned they still have.
He explained that there was indeed boosting of antibodies, but there is no standard for boosting, so it’s hard to say how much there even was in the study.
Bloomberg suggested the FDA may opt for a half dose for the booster shot, which would help Moderna spread faster as well as diminish the side effects.
Make FL1 part of your day.
Local reporting. Useful updates. More ways to stay close to your community.
Go ad-free
Support independent local reporting and enjoy FL1 without display ads.
$4.99 / month
Become a member →Cancel anytime. Third-party media players may contain ads.Get the daily briefing
Start your morning with the headlines that matter across the Finger Lakes.
Find more FL1 on Google
Choose FingerLakes1.com as a preferred source to see more of our reporting in your Google news results.





